The chromosomal location of two genetic loci involved in the transport of cyanocobalamin (B12) in Escherichia coli K-12 was determined. One gene, btuA, is believed to code for the transport protein in the cytoplasmic membrane, because a mutant with an alteration in this gene has lost the ability to accumulate B12 within the cell although normal levels of the surface receptors for B12 are present. The other locus, btuB, apparently codes for the surface receptor on the outer membrane. These mutants have lost the ability to bind B12 and have greatly reduced transport activity, although growth experiments have shown that they can utilize B12 for growth, but with decreased efficiency. This surface receptor for B12 also appears to function as the receptor for the E colicins, because btuB mutants are resistant to the E colicins, and mutants selected for resistance to colicin El are defective in B12 binding and transport. The gene order was determined by transduction analysis to be cyc-argH-btuA-btuB-rif-purD. In addition, mutations in metH, the gene for the B,2-dependent homocysteine methylating enzyme, were obtained in this study. This gene was localized between metA and malB.
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The uptake of cyanocobalamin (B12) by whole cells of Escherichia coli is a biphasic process consisting of an initial rapid phase, which is independent of the energy metabolism of the cell, followed by an energy-dependent phase (7).
The initial B,2-binding sites are firmly embedded in the outer membrane of the cell envelope (19) . Small amounts of B12-binding activity are released from cells by osmotic shock, and these have been separated into two discrete fractions with molecular weights of 22,000 and > 200,000 (17, 18) . Strains of E. coli that are defective in either phase of B12 uptake have been isolated and described (8) . Those cells lacking the initial phase have undetectable amounts of the receptor on the outer membrane but normal amounts of the smaller protein released by osmotic shock treatment. The mutant lacking the secondary phase while retaining the initial phase has normal amounts of all binding activities (19) .
The accompanying paper suggests that the initial B12-binding receptor also functions as a receptor for colicins El and E3 (9) . Binding of B12 to an outer membrane fraction or to whole cells is inhibited by these colicins. Conversely, colicin binding to cells is competitively inhibited by B12. Further, the mutants lacking the initial phase of B12 uptake are resistant to colicin action. The objective of this paper is to define the chromosomal location of two genes involved in Bl2 transport and to give some indication of the role of the B12-binding component in the transport process. The genotype btu is suggested to designate those genes involved in the uptake or utilization of B12. This paper provides genetic evidence also suggesting the identity of gene btuB, the locus controlling the initial phase of B12 uptake, and bfe, which has been described as the locus specifying the receptor for the three colicins E and for the bacteriophage BF23 (11) .
MATERIALS AND METHODS Media. The complex medium was LB broth (13) . The minimal medium A was that described by Davis and Mingioli (5) . Required growth factors were added to minimal media to these concentrations: glucose, 0.5%; amino acids, 100 ,ug/ml; purines and pyrimi-GENETICS OF VITAMIN B12 TRANSPORT gg/ml), or cystathionine (50 ,g/ml). Utilization of maltose was scored by growth on plates supplemented with 0.4% maltose.
Bacterial strains. The properties of the E. coli K strains used in this study are listed in Table 1 . Strain RK4101 was constructed by the transduction of a purE+ derivative of strain KBT041 to btuA+ by a P1 lysate grown on strain AT2535 (argHl). More than 70% of the btu+ recombinants had received the donor argH allele. From one of these recombinants, a strain resistant to cycloserine and rifampin was isolated by sequential selection.
Transduction and mating procedures. Donor Hfr cells were grown with aeration into the logarithmic phase of growth at 37 C, then allowed to stand at 37 C for 60 to 120 min before mating (3). Cells were mixed in a 1: 10 donor-recipient ratio and incubated at 37 C with gentle aeration. For determination of the time of entry of genetic markers, the mating mixture was gently diluted after 3 min with 10 volumes of prewarmed medium A containing 10% nutrient broth (10) . At intervals after dilution, portions of the mating mixture were pipetted into 3 ml of soft agar (0.75% agar in medium A) and subjected to mechanical agitation in the vibratory blending device of Low and Wood (12) . The mixture was poured onto selective plates.
Phage-mediated transductions were made by using phage Plkc. Lysates of donor strains with titers of 109 to 1011 infective particles per ml were prepared by the confluent plate lysis technique by using an inoculum of 103 to 104 infectious particles. Transduction crosses were carried out with a multiplicity of infection of 1 to 3 at 37 C for 20 min. The transduction mixture was plated directly onto recombinant-selective plates, which were then incubated for 36 to 48 h. CaCl2 (2.5 mM) was present during phage adsorption.
Characterization of recombinant colonies. Recombinant clones obtained on the selective plates were transferred with sterile toothpicks to a grid on Strain the same selective medium. This master plate was replicated to other selective plates to test for methionine auxotrophy, utilization of B12, etc. Resistance to rifampin was scored on plates no more than 5 days old because of its loss of biological activity. Colicin resistance was scored by applying an appropriate dilution of colicin El with a sterile toothpick to recombinant cells which had just been applied to a nutrient agar plate. The colicin preparations were obtained by the methods of Di Masi et al. (9) .
Mutants resistant to colicin El were selected by plating a mixture of 107 cells and colicin El in a soft-agar overlay on nutrient agar plates containing 100 ,g of streptomycin per ml to kill any of the cells contaminating the colicin preparation. Colonies surviving after overnight incubation at 42 C were purified by streaking for single-colony isolation.
Assays. The assays for the uptake of 6"Co-CN-B,2 have been previously described and they use a final B12 concentration of 4 nM (7). The activity of the cobalamin-dependent N5-methyltetrahydrofolatehomocysteine transmethylase was assayed in sonic extracts of cells by the method of Taylor and Weissbach (18) .
RESULTS
Three strains of E. coli defective in B12 uptake have been obtained after selection for the loss of ability to utilize B12 for methionine biosynthesis (8) . One of these mutants, KBT041, retained the initial phase of uptake but lost the secondary, energy-dependent phase. The two other mutants, KBT026 and KBT069, appeared to have lost both phases, because they were inactive in the normal transport assay. The apparent complexity of the uptake process suggests the functioning of several genes, two of 
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As RK4101, also argH+ 12 and 50%, respectively. This is consistent with before leu+ for strains KBT041 and the findings of others that the gene order in this )69, respectively. The times of entry indi-region of the chromosome is metB-cyc-argH--hat the mutations in strains KBT041 and btuA-rif-thi-purD (11, 15 ant to colicin El and E3 but sensitive to colicin K, whereas both the parental strain and the secondary phase mutant, KBT041, are sensitive to all of these colicins. Accordingly, the arg+ recombinants obtained in the transduction from strains KBT026 and KBT069 into strain RK4101 were tested for their resistance to colicin El. The colicin resistance of the donor strains was 66% co-transducible with argH (Table 3) . Analysis of the inheritance of the other unselected markers, rif and cyc, showed that the locus specifying sensitivity to colicin El was located between argH and rif. This location is quite similar to that of the locus bfe, which has been described as coding for the receptor for the phage BF23 and the three colicins E (11) . The locus in these strains specifying colicin resistance is called btuB, although it may be identical to bfe.
The relationship between the btuB locus and the initial phase of B12 uptake was further indicated by the measurement of the transport properties of some of the arg+ recombinants. Fifty-two colicin-resistant (Col-R) recombinants and 68 colicin-sensitive (Col-S) recombinants were assayed. All of the Col-R recombinants were defective in B12 uptake, averaging less than 5% of the wild-type level of either the initial or secondary phase of uptake. In contrast, all of the Col-S recombinants were normal in B12 uptake, exhibiting greater than 90% of the wild-type level of both the initial and secondary phases. This strongly suggests that the Col-R phenotype is related to the defect in the initial phase of B12 uptake.
Most of the btuB recombinants lacking the initial phase of uptake are able to utilize 3 ng of B12 per ml for growth. This allowed the genetic ordering of btuA and btuB. The recombinant strain RK4102 (metE, btuA41, btuB+, rif), which is unable to utilize B12 at any concentration, was used as the recipient. The donor strains on which P1 lysates were prepared were strains KBT026 and KBT069 (metE, btuB, rif+, metX), which are also unable to utilize B,2.
Selection was made for the ability to utilize 3 ng of B12 per ml. Such recombinants were obtained at frequencies approximately equal to that obtained with P1 grown on the parental strain KBT001. As had been predicted from the cotransduction frequencies of btuA and btuB with argH (0.84 and 0.67, respectively), 77% of the btuA+ recombinants had become Col-R ( btuA and btuB, two of the genes involved in B,2 transport. metH mutation in KBT026 and KBT069. The cross described above indicates that the mutations in btuB in strains KBT026 and KBT069 are not responsible for their Btuphenotype. This phenotype is 3% co-transducible with argH, compared to the 67% frequency for btuB. Enzyme assay for the metH gene product, the B,2-dependent homocysteine-N5-methyltetrahydrofolate transmethylase, showed that both of these strains lacked this activity. In addition, six arg+ recombinants of strain RK4101 that had received the Btu-phenotype from either strain KBT026 or KBT069 also lacked this activity, whereas seven arg+ btu+ recombinants from these crosses possessed wild-type levels of this activity. Four arg+ btu recombinants from the crosses with strain KBT- binants were btuB+ and possessed 100% of the wild-type level of B12 uptake, whereas the btuB recombinants were completely defective in transport. Therefore, it appears that strains KBT026 and KBT069 were isolated as double mutants defective both in metH, which conferred the Btu-phenotype, and in btuB, which eliminated B,2 transport.
Mapping of metH. The chromosomal location of metH has been described in Salmonella typhimurium as being between metA and malB (1). The metH mutation in our E. coli strains was mapped by transduction crosses in which the P1 lysate was prepared on strain PA505MPE11 (metH+, metE+, metA, malB). The recipients were strains RK4106 (metE, metH69, btuB69, metA+, malB+) and RK4105 (metE, metH26, btuB26, metA+, malB+). Transductants were selected for their ability to grow on B12; cystathionine was added to the selection plates to allow the growth of any metA recombinants. Of the recombinants obtained in either cross, 74% had lost their methionine auxotrophy, i.e., had become metE+. The genotypes of the remaining metE metH+ recombinants are shown in Table 5 . The data from the two crosses are essentially identical and are most consistent with the gene order metAmetH-maiB, because of the absence of a minority recombinant class which any other proposed gene order would require. The metH locus appears to be roughly equidistant between metA and malB.
Role of the initial phase of transport on B12 utilization. The ability of mutants lacking the initial phase of transport to utilize B12 at 3 ng/ml, despite their inactivity in the transport assay, has been described above. Growth of various pairs of btuB+ and btuB strains on different initial supplements of B12 was meas- ured to define the role of the initial phase in B12 utilization. The inoculum for these studies was grown in 10 ng of B12 per ml in order to avoid the long lag which resulted upon transfer of cells from a methionine-supplemented medium to a B12-supplemented medium. The exponential growth rate constant was determined for cultures inoculated into minimal media containing initial B12 concentrations from 0.13 to 6.13 ng/ml. The observed growth rate constants for strains RK4107 (metE, btuB+), RK4103 (metE, btuB26 and RK4104 (metE, btu69) as a function of B12 concentration are shown in Fig.  2 . Figure 3 presents an Eadie plot of this data in which the background growth of unsupplemented cultures is subtracted from the observed rate. Each point is the average of triplicate determinations. The btuB+ strains had an average, uncorrected maximal doubling time with B12 of about 65 min, whereas the btuB strains averaged 74 to 79 min. All strains had the same doubling time (56 to 60 min) when supplemented with methionine. These strains showed marked differences in their apparent Km for growth. The btuB+ strains achieved half the maximal growth rate at a B12 concentration of 0.15 to 0.20 nM, compared with 0.85 to 0.90 nM for the btuB strains. Thus the loss of the initial phase decreased the affinity of the cell for B12 as assayed either by transport assay or by growth measurements.
Properties of Col-R mutants. The close relationship of the colicin receptor and the initial phase of B12 uptake was further demonstrated by the properties of mutants selected for colicin resistance. Out of 24 mutants resistant to colicin El, 20 showed decreased utilization of B12 for growth and had the B12 uptake properties similar to strain KBT026 or strain KBT069. The remaining four isolates had normal uptake and B12 utilization, but at least three of these were still sensitive to colicin E3, in contrast to the former 20, which were resistant. These latter isolates were probably altered in some site of colicin action other than the receptor. DISCUSSION This paper has described two genetic loci, btuA and btuB, which are involved in the the growth rate was determined from
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thesis. In fact, these strains are double mutants.
There is mutation in metH that is responsible for their inability to utilize B12, in addition to the mutation in btuB affecting their uptake of B12. The metH mutation has no significant effect on B12 uptake or colicin resistance. The chromosomal location of metH was determined and is analogous to the location of metH in S.
typhimurium (1) .
Recombinant strains with a mutation in btuB, but metH+, are able to utilize B12 for growth. However, they require roughly a fivefold-higher concentration of B12 to achieve the same growth rate as a btuB+ strain. Paradoxi-I cally, these btuB strains possess no B12 trans- for the secondary phase of uptake (0.4 nM) (P.
M. DiGirolamo and C. Bradbeer, personal com-2. This uptake consists of two munication). Thus, the receptor plays a role in Zntial phases (7) . The first phase B12 transport, since its loss significantly de- binding of the B12 to specific creases both the affinity of the cell for B12 and which are firmly attached to the its maximal apparent rate of transport.
